Rheumatoid Arthritis

Follow along on our year-long guide to Rheumatoid Arthritis, an exploration of the latest recommendations and research on the diagnosis, treatment, management, and prevention of this inflammatory autoimmune condition. Each month will delve into another aspect, including warning signs, risk factors, and immune system triggers; management of pain, stiffness, swollen joints, and fatigue; medication options; reducing infection and other long-term risks; emotional, psychosocial, and reproductive/sexual health concerns; comorbidities; advising patients about self-care related to diet, exercise, and overall well-being to optimally live with the disease; special COVID-19 considerations; promising treatments in the pipeline; lessons learned from unique case studies, and more, all of which has undergone expert review. Every installment will include a downloadable, printable information resource for patients.

–At play in rheumatoid arthritis are autoantibodies, genetic factors, and environmental exposures

Patient Handout

–The pattern of joint involvement in rheumatoid arthritis is key

Patient Handout

–Focus on methotrexate, and here are other key considerations

Patient Handout

–What to watch for to avoid rheumatoid vasculitis

–Targeting TNF, triple therapy, and questions about JAK inhibitors

Patient Handout

–Disease risk is higher, and vaccines are crucial

Patient Handout

–Optimizing fertility, contraception, and pregnancy outcomes

Patient Handout

–Accurate diagnosis of rheumatoid arthritis finally made despite deviation from guideline criteria

–Risk for depression is particularly high, but help is available

Patient Handout

–Risks are increased, and assessment remains challenging

Patient Handout

–Emerging focus is on the fibroblast

Patient Handout

–Current emphasis is on tapering therapy for patients in remission

Patient Handout

Atopic Dermatitis Cardiomyopathy Endometriosis Heart Failure Melanoma Osteoporosis Rheumatoid Arthritis Ulcerative Colitis Urothelial Cancer